Abstract
Drug information must be provided by multiple modalities—direct, verbal, telephonic, audiotext message, fax back and visual by monitor—to meet the patient's and public need, to be successful in the marketplace. Ability to make tablet and capsule identifications is critical to avoid participating in the caller's uncertainty. An innovative tablet and capsule identification method using electronic search of the logo and alphabetic and numeric imprint on the drug product is discussed. Service to the public and professions alike is provided on a "pay by call" basis, by subscription and under contract.
Get full access to this article
View all access options for this article.
